{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:55:05Z","timestamp":1793386505714,"version":"4.5.0"},"reference-count":126,"publisher":"American Medical Association (AMA)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,6,15]]},"DOI":"10.1001\/jama.2021.7939","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T15:01:13Z","timestamp":1623769273000},"page":"2357","source":"Crossref","is-referenced-by-count":152,"title":["Acute Treatments for Episodic Migraine in Adults"],"prefix":"10.1001","volume":"325","author":[{"given":"Juliana H.","family":"VanderPluym","sequence":"first","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Center, Rochester, Minnesota"},{"name":"Department of Neurology, Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi B.","family":"Halker Singh","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Center, Rochester, Minnesota"},{"name":"Department of Neurology, Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Urtecho","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Center, Rochester, Minnesota"},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison S.","family":"Morrow","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Center, Rochester, Minnesota"},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Nayfeh","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Center, Rochester, Minnesota"},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor D.","family":"Torres Roldan","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Center, Rochester, Minnesota"},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdoleen H.","family":"Farah","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Center, Rochester, Minnesota"},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar","family":"Hasan","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Center, Rochester, Minnesota"},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Saadi","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Center, Rochester, Minnesota"},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahrish","family":"Shah","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Center, Rochester, Minnesota"},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Abd-Rabu","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Center, Rochester, Minnesota"},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Daraz","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Center, Rochester, Minnesota"},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J.","family":"Prokop","sequence":"additional","affiliation":[{"name":"Department of Library\u2013Public Services, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hassan","family":"Murad","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Center, Rochester, Minnesota"},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-based Practice Center, Rochester, Minnesota"},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"},{"name":"Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"11","key":"joi210056r1","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","article-title":"Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"17","author":"GBD 2016 Headache Collaborators","year":"2018","journal-title":"Lancet Neurol"},{"issue":"10258","key":"joi210056r2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet."},{"issue":"1","key":"joi210056r3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS): the International Classification of Headache Disorders, 3rd edition.","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"issue":"5","key":"joi210056r4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1177\/0333102417716933","article-title":"Do racial\/ethnic disparities exist in recommended migraine treatments in US ambulatory care?","volume":"38","author":"Charleston IV","year":"2018","journal-title":"Cephalalgia"},{"key":"joi210056r5","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"joi210056r6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jclinepi.2017.12.004","article-title":"Recommendations for assessing the risk of bias in systematic reviews of health-care interventions.","volume":"97","author":"Viswanathan","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"joi210056r7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews.","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"joi210056r8","article-title":"Design, analysis, and reporting of crossover trials for inclusion in a meta-analysis.","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"joi210056r9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12874-015-0091-1","article-title":"Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies.","volume":"15","author":"R\u00f6ver","year":"2015","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"joi210056r11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/(ISSN)1099-1557","article-title":"Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.","volume":"13","author":"Ashcroft","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"joi210056r12","article-title":"Zolmitriptan for acute migraine attacks in adults.","volume":"2014","author":"Bird","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"joi210056r13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1046\/j.1468-2982.2001.00169.x","article-title":"Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials.","volume":"21","author":"Ferrari","year":"2001","journal-title":"Cephalalgia"},{"issue":"6","key":"joi210056r14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/jcp.2005.30.issue-6","article-title":"Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials.","volume":"30","author":"Poolsup","year":"2005","journal-title":"J Clin Pharm Ther"},{"issue":"8","key":"joi210056r15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/hed.2007.47.issue-8","article-title":"Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.","volume":"47","author":"Chen","year":"2007","journal-title":"Headache"},{"issue":"2","key":"joi210056r16","article-title":"Sumatriptan (oral route of administration) for acute migraine attacks in adults.","author":"Derry","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"joi210056r17","article-title":"Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults.","author":"Derry","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"joi210056r18","article-title":"Diclofenac with or without an antiemetic for acute migraine headaches in adults.","author":"Derry","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"joi210056r19","article-title":"Ibuprofen with or without an antiemetic for acute migraine headaches in adults.","volume":"2013","author":"Rabbie","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"joi210056r20","article-title":"Aspirin with or without an antiemetic for acute migraine headaches in adults.","author":"Kirthi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"joi210056r21","article-title":"Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.","volume":"4","author":"Law","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"10200","key":"joi210056r22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0140-6736(19)31606-X","article-title":"Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.","volume":"394","author":"Croop","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"joi210056r23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1811090","article-title":"Rimegepant, an oral calcitonin gene-related peptide receptor antagonist, for migraine.","volume":"381","author":"Lipton","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"joi210056r24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/0333102413500727","article-title":"BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial.","volume":"34","author":"Marcus","year":"2014","journal-title":"Cephalalgia"},{"issue":"9","key":"joi210056r25","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1177\/0333102416653233","article-title":"A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine.","volume":"36","author":"Voss","year":"2016","journal-title":"Cephalalgia"},{"issue":"23","key":"joi210056r26","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1056\/NEJMoa1813049","article-title":"Ubrogepant for the treatment of migraine.","volume":"381","author":"Dodick","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"joi210056r27","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1001\/jama.2019.16711","article-title":"Effect of ubrogepant vs placebo on pain and the most bothersome associated symptom in the acute treatment of migraine: the ACHIEVE II randomized clinical trial.","volume":"322","author":"Lipton","year":"2019","journal-title":"JAMA"},{"issue":"11","key":"joi210056r28","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1177\/0333102419864132","article-title":"Interim results of a prospective, randomized, open-label, phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study).","volume":"39","author":"Brandes","year":"2019","journal-title":"Cephalalgia"},{"issue":"5","key":"joi210056r29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1474-4422(12)70047-9","article-title":"Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study.","volume":"11","author":"F\u00e4rkkil\u00e4","year":"2012","journal-title":"Lancet Neurol"},{"issue":"10","key":"joi210056r30","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1177\/0333102410375512","article-title":"Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan: a randomised proof-of-concept trial.","volume":"30","author":"Ferrari","year":"2010","journal-title":"Cephalalgia"},{"issue":"7","key":"joi210056r31","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1093\/brain\/awz134","article-title":"Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine.","volume":"142","author":"Goadsby","year":"2019","journal-title":"Brain"},{"issue":"24","key":"joi210056r32","doi-asserted-by":"publisher","first-page":"e2222","DOI":"10.1212\/WNL.0000000000006641","article-title":"Lasmiditan is an effective acute treatment for migraine: a phase 3 randomized study.","volume":"91","author":"Kuca","year":"2018","journal-title":"Neurology"},{"key":"joi210056r33","article-title":"Long-term safety and efficacy of lasmiditan for acute treatment of migraine: final results of the GLADIATOR study.","volume":"3","author":"Brandes","year":"2020","journal-title":"Cephalalgia Rep."},{"issue":"3","key":"joi210056r34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/0333102421989232","article-title":"Randomized, controlled trial of lasmiditan over four migraine attacks: findings from the CENTURION study.","volume":"41","author":"Ashina","year":"2021","journal-title":"Cephalalgia"},{"issue":"1","key":"joi210056r35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/0333102419889350","article-title":"Lasmiditan for the acute treatment of migraine: subgroup analyses by prior response to triptans.","volume":"40","author":"Knievel","year":"2020","journal-title":"Cephalalgia"},{"issue":"2","key":"joi210056r36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.tjem.2016.12.004","article-title":"Comparison of granisetron and metoclopramide in the treatment of pain and emesis in migraine patients: a randomized controlled trial study.","volume":"17","author":"Amiri","year":"2017","journal-title":"Turk J Emerg Med"},{"issue":"2","key":"joi210056r37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0736-4679(02)00502-4","article-title":"Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial.","volume":"23","author":"Bigal","year":"2002","journal-title":"J Emerg Med"},{"issue":"7","key":"joi210056r38","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/acem.1995.2.issue-7","article-title":"Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache.","volume":"2","author":"Cameron","year":"1995","journal-title":"Acad Emerg Med"},{"issue":"3","key":"joi210056r39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1468-2982.2004.00840.x","article-title":"A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs metoclopramide in the management of acute migraine attacks in the emergency department.","volume":"25","author":"Cete","year":"2005","journal-title":"Cephalalgia"},{"issue":"5","key":"joi210056r40","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0196-0644(95)70001-3","article-title":"Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache.","volume":"26","author":"Coppola","year":"1995","journal-title":"Ann Emerg Med"},{"issue":"6","key":"joi210056r41","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1067\/mem.2001.119424","article-title":"Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache.","volume":"38","author":"Corbo","year":"2001","journal-title":"Ann Emerg Med"},{"issue":"10","key":"joi210056r42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1742-1241.1985.tb07866.x","article-title":"Double-blind controlled study of Paramax in the acute treatment of common and classical migraine.","volume":"39","author":"Dexter","year":"1985","journal-title":"Br J Clin Pract"},{"issue":"4","key":"joi210056r43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/ane.13063","article-title":"Intravenous metoclopramide in the treatment of acute migraines: a randomized, placebo-controlled trial.","volume":"139","author":"Dogan","year":"2019","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"joi210056r44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/ane.2019.140.issue-1","article-title":"Buccally absorbed vs intravenous prochlorperazine for treatment of migraines headaches.","volume":"140","author":"Fernando","year":"2019","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"joi210056r45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.annemergmed.2007.09.027","article-title":"A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine.","volume":"52","author":"Friedman","year":"2008","journal-title":"Ann Emerg Med"},{"issue":"5","key":"joi210056r46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.annemergmed.2010.11.023","article-title":"Metoclopramide for acute migraine: a dose-finding randomized clinical trial.","volume":"57","author":"Friedman","year":"2011","journal-title":"Ann Emerg Med"},{"issue":"1","key":"joi210056r47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.annemergmed.2015.07.495","article-title":"Diphenhydramine as adjuvant therapy for acute migraine: an emergency department\u2013based randomized clinical trial.","volume":"67","author":"Friedman","year":"2016","journal-title":"Ann Emerg Med"},{"issue":"3","key":"joi210056r48","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jemermed.2015.03.023","article-title":"A randomized controlled trial of intravenous haloperidol vs intravenous metoclopramide for acute migraine therapy in the emergency department.","volume":"49","author":"Gaffigan","year":"2015","journal-title":"J Emerg Med"},{"issue":"5","key":"joi210056r49","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/hed.2006.46.issue-5","article-title":"Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study.","volume":"46","author":"Honkaniemi","year":"2006","journal-title":"Headache"},{"issue":"2","key":"joi210056r50","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0196-0644(94)70135-0","article-title":"Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department.","volume":"24","author":"Jones","year":"1994","journal-title":"Ann Emerg Med"},{"issue":"3","key":"joi210056r51","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0735-6757(96)90171-0","article-title":"Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache.","volume":"14","author":"Jones","year":"1996","journal-title":"Am J Emerg Med"},{"issue":"7","key":"joi210056r52","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S0196-0644(87)80569-3","article-title":"Treatment of migraine with intramuscular chlorpromazine.","volume":"16","author":"McEwen","year":"1987","journal-title":"Ann Emerg Med"},{"issue":"2","key":"joi210056r53","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ajem.2008.01.015","article-title":"Randomized evaluation of octreotide vs prochlorperazine for ED treatment of migraine headache.","volume":"27","author":"Miller","year":"2009","journal-title":"Am J Emerg Med"},{"issue":"5","key":"joi210056r54","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1468-2982.1991.1105207.x","article-title":"A double-blind comparison of granisetron and placebo for the treatment of acute migraine in the emergency department.","volume":"11","author":"Rowat","year":"1991","journal-title":"Cephalalgia"},{"issue":"2","key":"joi210056r55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/157488911795933947","article-title":"Metoclopramide as an analgesic in severe migraine attacks: an open, single-blind, parallel control study.","volume":"6","author":"Salazar","year":"2011","journal-title":"Recent Pat CNS Drug Discov"},{"issue":"1","key":"joi210056r56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jemermed.2014.06.055","article-title":"Comparison of therapeutic effects of magnesium sulfate vs dexamethasone\/metoclopramide on alleviating acute migraine headache.","volume":"48","author":"Shahrami","year":"2015","journal-title":"J Emerg Med"},{"issue":"2","key":"joi210056r57","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1212\/01.WNL.0000042477.63516.B2","article-title":"Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial.","volume":"60","author":"Silberstein","year":"2003","journal-title":"Neurology"},{"issue":"10","key":"joi210056r58","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0196-0644(05)81508-2","article-title":"A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department.","volume":"19","author":"Tek","year":"1990","journal-title":"Ann Emerg Med"},{"issue":"6","key":"joi210056r59","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1067\/mem.2003.195","article-title":"Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial.","volume":"41","author":"Tanen","year":"2003","journal-title":"Ann Emerg Med"},{"key":"joi210056r60","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ajem.2020.09.033","article-title":"MAGraine: Magnesium compared to conventional therapy for treatment of migraines.","volume":"39","author":"Kandil","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"5","key":"joi210056r61","first-page":"369","article-title":"Magnesium sulfate and acute migraine: a randomized clinical trial.","volume":"11","author":"Motamed","year":"2020","journal-title":"Ann Clin Anal Med."},{"issue":"4","key":"joi210056r62","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/hed.2011.51.issue-4","article-title":"MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.","volume":"51","author":"Aurora","year":"2011","journal-title":"Headache"},{"issue":"6","key":"joi210056r63","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/hed.2009.49.issue-6","article-title":"A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.","volume":"49","author":"Aurora","year":"2009","journal-title":"Headache"},{"issue":"10","key":"joi210056r64","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0196-0644(05)81507-0","article-title":"A comparative trial of three agents in the treatment of acute migraine headache.","volume":"19","author":"Bell","year":"1990","journal-title":"Ann Emerg Med"},{"issue":"4","key":"joi210056r65","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/hed.1986.26.issue-4","article-title":"A controlled study of dihydroergotamine in the treatment of acute migraine headache.","volume":"26","author":"Callaham","year":"1986","journal-title":"Headache"},{"issue":"2","key":"joi210056r66","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000047960","article-title":"Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.","volume":"47","author":"Diener","year":"2002","journal-title":"Eur Neurol"},{"issue":"1","key":"joi210056r67","first-page":"170","article-title":"Symptomatic relief of migraine: multicenter comparison of Cafergot P-B, Cafergot, and placebo.","volume":"11","author":"Friedman","year":"1989","journal-title":"Clin Ther"},{"issue":"12","key":"joi210056r68","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1001\/archneur.1996.00550120097022","article-title":"Acute treatment of migraine with dihydroergotamine nasal spray.","volume":"53","author":"Gallagher","year":"1996","journal-title":"Arch Neurol"},{"issue":"1","key":"joi210056r69","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/hed.1982.22.issue-1","article-title":"Ergotamine vs metoclopramide vs their combination in acute migraine attacks.","volume":"22","author":"Hakkarainen","year":"1982","journal-title":"Headache"},{"issue":"5","key":"joi210056r70","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/joim.1992.231.issue-5","article-title":"Ketoprofen and ergotamine in acute migraine.","volume":"231","author":"Kangasniemi","year":"1992","journal-title":"J Intern Med"},{"issue":"4","key":"joi210056r71","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/hed.1995.35.issue-4","article-title":"Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine.","volume":"35","author":"Rapoport","year":"1995","journal-title":"Headache"},{"issue":"4","key":"joi210056r72","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/hed.1970.9.issue-4","article-title":"Double-blind clinical evaluation of the efficacy and safety of ergostine-caffeine, ergotamine-caffeine, and placebo in migraine headache.","volume":"9","author":"Ryan","year":"1970","journal-title":"Headache"},{"issue":"9","key":"joi210056r73","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1046\/j.1526-4610.2002.02210.x","article-title":"Efficacy and tolerability of prochlorperazine buccal tablets in treatment of acute migraine.","volume":"42","author":"Sharma","year":"2002","journal-title":"Headache"},{"issue":"8","key":"joi210056r74","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1046\/j.1526-4610.1998.3808614.x","article-title":"Dihydroergotamine nasal spray in the treatment of acute migraine.","volume":"38","author":"Treves","year":"1998","journal-title":"Headache"},{"issue":"2","key":"joi210056r75","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1468-2982.1987.0702131.x","article-title":"Dihydroergotamine nasal spray during migraine attacks: a double-blind crossover study with placebo.","volume":"7","author":"Tulunay","year":"1987","journal-title":"Cephalalgia"},{"issue":"3 pt 1","key":"joi210056r76","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1212\/WNL.44.3_Part_1.447","article-title":"Dihydroergotamine nasal spray for the acute treatment of migraine.","volume":"44","author":"Ziegler","year":"1994","journal-title":"Neurology"},{"issue":"7","key":"joi210056r77","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.clinthera.2007.07.017","article-title":"Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial.","volume":"29","author":"Alemdar","year":"2007","journal-title":"Clin Ther"},{"issue":"2","key":"joi210056r78","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1046\/j.1468-2982.1994.1402156.x","article-title":"Double-blind comparison of an acetaminophen 400 mg\u2013codeine 25 mg combination versus aspirin 1000 mg and placebo in acute migraine attack.","volume":"14","author":"Boureau","year":"1994","journal-title":"Cephalalgia"},{"issue":"2","key":"joi210056r79","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0196-0644(98)70126-X","article-title":"Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache.","volume":"32","author":"Carleton","year":"1998","journal-title":"Ann Emerg Med"},{"key":"joi210056r80","first-page":"22","article-title":"The acute treatment of migraine with transnasal butorphanol (TNB).","volume":"4","author":"Freitag","year":"1993","journal-title":"Headache Q"},{"issue":"20","key":"joi210056r81","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1212\/WNL.0000000000004642","article-title":"Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine.","volume":"89","author":"Friedman","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"joi210056r82","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/hed.1995.35.issue-2","article-title":"Transnasal butorphanol in the treatment of acute migraine.","volume":"35","author":"Hoffert","year":"1995","journal-title":"Headache"},{"issue":"10","key":"joi210056r83","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/hed.1993.33.issue-10","article-title":"Current emergency treatment of severe migraine headaches.","volume":"33","author":"Klapper","year":"1993","journal-title":"Headache"},{"issue":"4","key":"joi210056r84","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0196-0644(89)80570-0","article-title":"Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache.","volume":"18","author":"Lane","year":"1989","journal-title":"Ann Emerg Med"},{"issue":"1","key":"joi210056r85","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1053\/ajem.2002.30007","article-title":"A randomized clinical trial to assess the efficacy of intramuscular droperidol for the treatment of acute migraine headache.","volume":"20","author":"Richman","year":"2002","journal-title":"Am J Emerg Med"},{"issue":"5","key":"joi210056r86","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/hed.1995.35.issue-5","article-title":"Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine.","volume":"35","author":"Scherl","year":"1995","journal-title":"Headache"},{"issue":"10","key":"joi210056r87","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1526-4610.2005.00264.x","article-title":"Tramadol\/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial.","volume":"45","author":"Silberstein","year":"2005","journal-title":"Headache"},{"issue":"11","key":"joi210056r88","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/S0196-0644(05)81471-4","article-title":"Methotrimeprazine versus meperidine and dimenhydrinate in the treatment of severe migraine: a randomized, controlled trial.","volume":"20","author":"Stiell","year":"1991","journal-title":"Ann Emerg Med"},{"issue":"12","key":"joi210056r89","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3923\/pjbs.2011.682.687","article-title":"Intravenous dexamethasone versus morphine in relieving of acute migraine headache.","volume":"14","author":"Taheraghdam","year":"2011","journal-title":"Pak J Biol Sci"},{"issue":"4","key":"joi210056r90","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1742-1241.2009.02215.x","article-title":"Cutaneous application of menthol 10% solution as an abortive treatment of migraine without aura: a randomised, double-blind, placebo-controlled, crossed-over study.","volume":"64","author":"Borhani Haghighi","year":"2010","journal-title":"Int J Clin Pract"},{"issue":"1","key":"joi210056r91","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0333102418811573","article-title":"Acute migraine therapy with external trigeminal neurostimulation (ACME): a randomized controlled trial.","volume":"39","author":"Chou","year":"2019","journal-title":"Cephalalgia"},{"issue":"6","key":"joi210056r92","article-title":"Pain management using acupuncture method in migraine headache patients: a single blinded randomized clinical trial.","volume":"8","author":"Farahmand","year":"2018","journal-title":"Anesth Pain Med"},{"issue":"10","key":"joi210056r93","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1177\/0333102418797285","article-title":"Treatment of acute migraine by a partial rebreathing device: a randomized controlled pilot study.","volume":"38","author":"Fuglsang","year":"2018","journal-title":"Cephalalgia"},{"issue":"3","key":"joi210056r94","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/ane.2018.138.issue-3","article-title":"The effectiveness of greater occipital nerve blockade in treating acute migraine-related headaches in emergency departments.","volume":"138","author":"Korucu","year":"2018","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"joi210056r95","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/hed.2009.49.issue-6","article-title":"Acupuncture for treating acute attacks of migraine: a randomized controlled trial.","volume":"49","author":"Li","year":"2009","journal-title":"Headache"},{"issue":"4","key":"joi210056r96","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S1474-4422(10)70054-5","article-title":"Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.","volume":"9","author":"Lipton","year":"2010","journal-title":"Lancet Neurol"},{"issue":"1","key":"joi210056r97","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1891\/1933-3196.2.1.15","article-title":"Phase 1 of integrated EMDR: an abortive treatment for migraine headaches.","volume":"2","author":"Marcus","year":"2008","journal-title":"J EMDR Pract Res."},{"key":"joi210056r98","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ctim.2017.07.009","article-title":"Efficacy of topical rose (Rosa damascena Mill.) oil for migraine headache: a randomized double-blinded placebo-controlled cross-over trial.","volume":"34","author":"Niazi","year":"2017","journal-title":"Complement Ther Med"},{"issue":"5","key":"joi210056r99","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000335249","article-title":"Lavender essential oil in the treatment of migraine headache: a placebo-controlled clinical trial.","volume":"67","author":"Sasannejad","year":"2012","journal-title":"Eur Neurol"},{"issue":"4","key":"joi210056r100","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1212\/WNL.0000000000005857","article-title":"Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study.","volume":"91","author":"Tassorelli","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"joi210056r101","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0735-6757(99)90118-3","article-title":"Nitrous oxide for the treatment of acute migraine headache.","volume":"17","author":"Triner","year":"1999","journal-title":"Am J Emerg Med"},{"issue":"5","key":"joi210056r102","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1526-4637.2012.01376.x","article-title":"Efficacy of acupuncture for acute migraine attack: a multicenter single blinded, randomized controlled trial.","volume":"13","author":"Wang","year":"2012","journal-title":"Pain Med"},{"key":"joi210056r103","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1472-6882-12-S1-P123","article-title":"A PET-CT study on the specificity of acupoints through acupuncture treatment in migraine patients.","volume":"12","author":"Yang","year":"2012","journal-title":"BMC Complement Altern Med"},{"issue":"8","key":"joi210056r104","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/head.v59.8","article-title":"Remote electrical neuromodulation (REN) relieves acute migraine: a randomized, double-blind, placebo-controlled, multicenter trial.","volume":"59","author":"Yarnitsky","year":"2019","journal-title":"Headache"},{"issue":"13","key":"joi210056r105","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1212\/WNL.0000000000003760","article-title":"Nonpainful remote electrical stimulation alleviates episodic migraine pain.","volume":"88","author":"Yarnitsky","year":"2017","journal-title":"Neurology"},{"issue":"8","key":"joi210056r106","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s10072-018-3415-1","article-title":"Evaluation of the effect of topical chamomile (Matricaria chamomilla L.) oleogel as pain relief in migraine without aura: a randomized, double-blind, placebo-controlled, crossover study.","volume":"39","author":"Zargaran","year":"2018","journal-title":"Neurol Sci"},{"key":"joi210056r107","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajem.2020.01.024","article-title":"Treatment of migraine attacks by transcutaneous electrical nerve stimulation in emergency department: a randomize controlled trial.","volume":"39","author":"Hokenek","year":"2021","journal-title":"Am J Emerg Med."},{"issue":"11","key":"joi210056r108","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/brainsci10110888","article-title":"Low intensity, transcranial, alternating current stimulation reduces migraine attack burden in a home application set-up: a double-blinded, randomized feasibility study.","volume":"10","author":"Antal","year":"2020","journal-title":"Brain Sci"},{"issue":"1","key":"joi210056r109","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/head.2015.55.issue-1","article-title":"The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies.","volume":"55","author":"Marmura","year":"2015","journal-title":"Headache"},{"issue":"10","key":"joi210056r110","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/head.13179","article-title":"Framingham-based cardiovascular risk estimates among people with episodic migraine in the US population: results from the American Migraine Prevalence and Prevention (AMPP) study.","volume":"57","author":"Lipton","year":"2017","journal-title":"Headache"},{"issue":"1","key":"joi210056r111","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/head.12962","article-title":"Cardiovascular events, conditions, and procedures among people with episodic migraine in the US population: results from the American Migraine Prevalence and Prevention (AMPP) study.","volume":"57","author":"Buse","year":"2017","journal-title":"Headache"},{"issue":"7","key":"joi210056r112","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/head.2016.56.issue-7","article-title":"How to apply the AHS evidence assessment of the acute treatment of migraine in adults to your patient with migraine.","volume":"56","author":"Pringsheim","year":"2016","journal-title":"Headache"},{"issue":"1","key":"joi210056r113","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s10194-019-1044-6","article-title":"Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials.","volume":"20","author":"Shapiro","year":"2019","journal-title":"J Headache Pain"},{"issue":"12","key":"joi210056r114","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12121180","article-title":"Pharmacokinetics, pharmacodynamics and drug-drug interactions of new anti-migraine drugs: lasmiditan, gepants, and calcitonin-gene-related peptide (CGRP) receptor monoclonal antibodies.","volume":"12","author":"Szkutnik-Fiedler","year":"2020","journal-title":"Pharmaceutics"},{"issue":"5","key":"joi210056r115","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2732","article-title":"Effects of lasmiditan on simulated driving performance: results of two randomized, blinded, crossover studies with placebo and active controls.","volume":"35","author":"Pearlman","year":"2020","journal-title":"Hum Psychopharmacol"},{"issue":"2","key":"joi210056r116","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/SPC.0000000000000126","article-title":"Conditioned pain modulation.","volume":"9","author":"Nir","year":"2015","journal-title":"Curr Opin Support Palliat Care"},{"key":"joi210056r117","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.92.15_supplement.S59.006","article-title":"Demographics, headache characteristics, and other factors associated with opioid use in people with migraine: results from the CaMEO study.","volume":"92","author":"Lipton","year":"2019","journal-title":"Neurology"},{"key":"joi210056r120","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/DHPS","article-title":"Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits.","volume":"10","author":"Molina","year":"2018","journal-title":"Drug Healthc Patient Saf"},{"issue":"9","key":"joi210056r121","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1177\/0333102419835465","article-title":"Long-term treatment patterns of prophylactic and acute migraine medications and incidence of opioid-related adverse events in patients with migraine.","volume":"39","author":"Bonafede","year":"2019","journal-title":"Cephalalgia"},{"key":"joi210056r122","doi-asserted-by":"crossref","DOI":"10.1097\/PEC.0000000000001851","article-title":"Rates and predictors of using opioids in the emergency department to treat migraine in adolescents and young adults.","author":"Connelly","year":"2019","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"joi210056r123","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1067\/mem.2003.24","article-title":"Variations among emergency departments in the treatment of benign headache.","volume":"41","author":"Vinson","year":"2003","journal-title":"Ann Emerg Med"},{"issue":"5","key":"joi210056r124","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1212\/01.WNL.0000113747.18760.D2","article-title":"Incidence and predictors for chronicity of headache in patients with episodic migraine.","volume":"62","author":"Katsarava","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"joi210056r125","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0304-3959(84)90067-8","article-title":"Drug abuse in migraine patients.","volume":"19","author":"Langemark","year":"1984","journal-title":"Pain"},{"issue":"2","key":"joi210056r126","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/0735-6757(94)90231-3","article-title":"An evaluation of the role of the ED in the management of migraine headaches.","volume":"12","author":"Salomone","year":"1994","journal-title":"Am J Emerg Med"},{"key":"joi210056r10","year":"2014"},{"key":"joi210056r118","author":"Lipton","year":"2019"},{"key":"joi210056r119","author":"Ashina","year":"2019"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2781052\/jama_vanderpluym_2021_oi_210056_1623359384.25754.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T21:12:40Z","timestamp":1725225160000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2781052"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":126,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2021,6,15]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.7939","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}